Status:
COMPLETED
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Breast Neoplasm
Hereditary Neoplastic Syndrome
Eligibility:
All Genders
Brief Summary
Women who are at high risk for breast cancer, either because of linkage to high risk breast and ovarian cancer families, or because of a carcinoma in the opposite breast, will be studied. Women will h...
Detailed Description
Women who are at high risk for breast cancer, either because of linkage to high risk breast and ovarian cancer families, or because of a carcinoma in the opposite breast, will be studied. Women will h...
Eligibility Criteria
Women at high risk for breast cancer, either because they are a member of a high risk breast or ovarian cancer family, or because of a carcinoma of the opposite breast.
Normal mammogram within past 3 months.
No suspicious breast or axillary lesions on physical examination.
No major cardiopulmonary, hepatic or renal disorders.
Key Trial Info
Start Date :
January 1 1996
Trial Type :
OBSERVATIONAL
End Date :
November 1 2001
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00001496
Start Date
January 1 1996
End Date
November 1 2001
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI)
Bethesda, Maryland, United States, 20892